Franklin Biotechnology Discovery R6 (FRBRX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

227.59

-1.54 (-0.67%)

At close: Aug 26, 2026

60.76% (1Y)

Fund Assets	1.15B
Expense Ratio	0.67%
Min. Investment	$1,000,000
Turnover	37.62%
Dividend (ttm)	3.98
Dividend Yield	1.75%
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 22, 2025

Previous Close	229.13
YTD Return	26.82%
1-Year Return	77.00%
5-Year Return	81.43%
52-Week Low	143.73
52-Week High	231.92
Beta (5Y)	0.94
Holdings	119
Inception Date	May 1, 2013

About FRBRX

The Franklin Biotechnology Discovery Fund is a mutual fund designed to provide capital appreciation by primarily investing in equity securities of biotechnology companies and discovery research firms. It focuses on capturing growth opportunities in the healthcare sector, particularly among biotechnology innovators. The fund's portfolio typically includes a mix of established large-cap companies and smaller, growth-oriented biotech firms. By concentrating on this niche, the fund plays a significant role in the healthcare investment landscape, allowing investors to tap into the potential of biotechnology advancements. Its investment strategy aligns with the broader NASDAQ Biotechnology Index, reflecting the performance of the biotechnology sector. The fund's role in the financial market is to offer a specialized investment vehicle for those interested in the healthcare industry's biotech segment.

Fund Family Franklin Templeton Investments

Category Health

Performance Rating Above Average

Risk Rating Above Average

Stock Exchange NASDAQ

Ticker Symbol FRBRX

Share Class Class R6

Index NASDAQ Biotechnology CR

Performance

FRBRX had a total return of 77.00% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.59%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
FTDZX	Advisor Class	0.77%
FBDIX	Class A	1.02%
FBTDX	Class C	1.77%

Top 10 Holdings

35.61% of assets

Name	Symbol	Weight
Jazz Pharmaceuticals plc	JAZZ	5.65%
Amgen Inc.	AMGN	4.39%
Gilead Sciences, Inc.	GILD	3.85%
Regeneron Pharmaceuticals, Inc.	REGN	3.76%
argenx SE	ARGX	3.62%
Vertex Pharmaceuticals Incorporated	VRTX	3.54%
Revolution Medicines, Inc.	RVMD	3.01%
Guardant Health, Inc.	GH	2.76%
Ascendis Pharma A/S	ASND	2.56%
Oruka Therapeutics, Inc.	ORKA	2.47%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$18.4014	Dec 22, 2025
Dec 20, 2024	$11.7607	Dec 20, 2024
Dec 20, 2022	$0.5857	Dec 20, 2022
Dec 15, 2021	$18.2831	Dec 15, 2021
Dec 15, 2020	$10.3921	Dec 15, 2020
Dec 16, 2019	$14.1643	Dec 18, 2019

Full Dividend History